Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $43

3/19/2026
Impact: 75
Healthcare

Canaccord Genuity analyst William Plovanic has maintained a Buy rating on HeartFlow (NASDAQ: HTFL) and increased the price target from $40 to $43.

AI summary, not financial advice

Share: